CDKN2B (p15 INK4b) monoclonal Antibody | MB62781

CDKN2B (p15 INK4b) monoclonal Antibody | MB62781 | Gentaur UK, US & Europe Distribution

Host: Mouse

Reactivity: Human, Mouse, Rat

Application: IF, IHC, WB

Application Range: WB 1:500~2000, IHC 1:150, IF 1:100

Background: This gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated and deleted in a wide variety of tumors. This gene encodes a cyclin-dependent kinase inhibitor, which forms a complex with CDK4 or CDK6, and prevents the activation of the CDK kinases, thus the encoded protein functions as a cell growth regulator that controls cell cycle G1 progression. The expression of this gene was found to be dramatically induced by TGF beta, which suggested its role in the TGF beta induced growth inhibition. Two alternatively spliced transcript variants of this gene, which encode distinct proteins, have been reported. [provided by RefSeq]

Storage & Stability: PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

Specificity: cyclin dependent kinase inhibitor 2B

Molecular Weight: 14.5 kDa (Predicted)

Note: For research use only, not for use in diagnostic procedure.

Alternative Names: CDK4I; INK4B; MTS2; P15; p15INK4b; TP15

Immunogen: Full length human recombinant protein of human CDKN2B (NP_004927) produced in HEK293T cell.

Conjugate: Unconjugated

Modification: Unmodification

Purification & Purity: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)

Pathway: N/A